Home
PAI Pharma

PAI Pharma Market Share Analysis for May 2026

Industry: N/A

Domainpaipharma.com

Year Founded1968

Employees501 - 1000

Annual Revenue$75M - $100M

PAI Pharma

PAI Pharma (including company regionals)

paipharma.com

See more website traffic and engagement information

PAI Pharma Revenue up to May 2026 is 75M - 100M

revenue generated by PAI Pharma top domains

PAI Pharma top domains revenue over 3 years

Revenue for PAI Pharma top domains

paipharma.com75M - 100M

See more with Sales Intelligence

Total visits to PAI Pharma's top domains

Understand PAI Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

paipharma.com14.1K

See more with Sales Intelligence

Avg. visit duration in PAI Pharma's top domains

Analyze PAI Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

paipharma.com00:01:46

See more with Sales Intelligence

Avg. pageviews on PAI Pharma's top domains

See how PAI Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

paipharma.com2.05

See more with Sales Intelligence

PAI Pharma top competitors by domain

Top similar sites in May 2026, ranked by their affinity

lannett.comCompany NameLannettEmployees1001 - 5000HQUnited States, Pennsylvania, TrevoseAnnual revenue$200M - $500MTotal visits12.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by PAI Pharma

These are the website technologies, by industry, used by PAI Pharma top domains

Mobile (3)

Meta Viewport

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Business Solutions (2)

Zoho

More Technologies

8

See all

News & Signals from PAI Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOlympus Partners acquires PA Inc.Monroe Capital supports Olympus Partners' acquisition of PAI Pharma.

NewsPA Inc acquires Nivagen Pharmaceuticals, Inc..PAI Pharma, which is backed by Olympus Partners, has acquired Nivagen Pharmaceuticals, Inc, a Sacramento, California-based pharmaceutical company.

NewsPA Inc sold assets to The Ritedose Corporation on Sep 7th '25.Ritedose recently acquired the Arformoterol Tartrate asset from PAI Pharma, effectively expanding its inhalation drug portfolio and strengthening its foothold in the market.